Ansun Biopharma, Inc.

📍 San Diego, United States🗓 Founded 2003👥 25 employees💰 Last funded Aug 2019
Biotechnology Research🌐 ansunbiopharma.com
Website LinkedIn
Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2003
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Ansun Biopharma, Inc.?
Ansun Biopharma, Inc. has 1 investors on record on gritt.io.
When did Ansun Biopharma, Inc. last raise funding?
The most recent investment in Ansun Biopharma, Inc. recorded on gritt.io was in August 2019.
When was Ansun Biopharma, Inc. founded?
Ansun Biopharma, Inc. was founded in 2003.
What industry is Ansun Biopharma, Inc. in?
Ansun Biopharma, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ansun Biopharma, Inc. based?
Ansun Biopharma, Inc. is headquartered in San Diego, United States.